Memorial Sloan Kettering Cancer Center

https://www.mskcc.org/healthcare-professionals

Refer a Patient to MSKCC: mskcc.org/refer

 

Current and Future Personalized Systemic Targets in Esophagogastric Cancer: Anti-HER2, Anti-VEGF, TAS-102, and Claudin 18.2

280 views
September 24, 2019
0 Comments
Login to view comments. Click here to Login
Gastrointestinal